Furosemide and Complement factor c3 decreased - a phase IV clinical study of FDA data

Summary:

Complement factor c3 decreased is reported as a side effect among people who take Furosemide (furosemide), especially for people who are female, 20-29 old, also take Cellcept, and have Haemolytic uraemic syndrome.

The phase IV clinical study analyzes which people have Complement factor c3 decreased when taking Furosemide. It is created by eHealthMe based on reports of 313,719 people who have side effects when taking Furosemide from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Complement factor c3 decreased?

Complement factor c3 decreased is found to be associated with 48 drugs and 202 conditions by eHealthMe. Check the latest studies of Complement factor c3 decreased.

On Jul, 07, 2026

313,719 people reported to have side effects when taking Furosemide.
Among them, 11 people (0.0%) have Complement factor c3 decreased.

Could Furosemide cause Complement factor c3 decreased?

Among these 11 people:

What is the gender of people who have Complement factor c3 decreased when taking Furosemide? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Complement factor c3 decreased when taking Furosemide? *

What are other drugs people take besides Furosemide? *

What are other side effects people have besides Complement factor c3 decreased? *

Acute Kidney Failure: 4 people, 36.36%
Blood Creatinine Increased: 3 people, 27.27%
Blood Albumin Decreased: 3 people, 27.27%
Protein Total Decreased: 2 people, 18.18%
Blood Bilirubin Increased: 2 people, 18.18%
Complement Factor C4 Decreased: 2 people, 18.18%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 18.18%
Complement Factor Decreased: 2 people, 18.18%
Hepatic Steatosis (fatty liver disease): 2 people, 18.18%
Oedema Peripheral (superficial swelling): 2 people, 18.18%

What are the existing conditions these people have? *

Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 18.18%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 2 people, 18.18%
Urinary Tract Infection: 1 person, 9.09%
Rickets (softening of bones): 1 person, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
Pain: 1 person, 9.09%
Joint Pain: 1 person, 9.09%
Depression: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and have Complement factor c3 decreased?

- Check whether Complement factor c3 decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Furosemide:

Furosemide (316,095 reports)

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Complement factor c3 decreased:

Complement factor c3 decreased (48 drugs)

Browse all the conditions that are associated with Complement factor c3 decreased:

Complement factor c3 decreased (202 conditions)

Related publications that referenced our studies

Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on furosemide (the active ingredients of Furosemide) and Furosemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.